Uncovering the mode of action of engineered T cells in patient cancer organoids

Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K.L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D. Meringa, Heggert G. Rebel, Maj Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary MillenTrudy Straetemans, Mara J.T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C.R. Ariese, Hannah R. Johnson, Ravian L. van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar-Ephraim, Kai Kretzschmar, Alexander M.M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyen, Anne C. Rios*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Uncovering the mode of action of engineered T cells in patient cancer organoids'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology